First-ever classification criteria for #haemochromatosis arthropathy now published! A major step for research & trials in this under-recognised condition. Thanks to the @eular.org task force who made this possible - a privilege to work together since 2020! www.sciencedirect.com/science/arti...

✨️MIHRA Membership✨️ is cost-free and strives for diverse and global inclusion. If you haven’t already registered for MIHRA membership, you are welcome to either follow the QR below or click this link for the MIHRA membership form: forms.gle/HmYbFxtPZFFu27… which takes about 5 minutes!

UCL Queen Square Institute of Neurology Summer Drinks, October Gallery, July 2025 ☺️

Great talk by @nathan-routledge.bsky.social from @uclqsneuromuscular.bsky.social on his Myositis UK-funded PhD: exploring disease pathways for IBM stratification and therapy. Delighted to be at the Myositis UK charity annual meeting, an event I’ve proudly contributed to for over a decade! #Myositis

Excellent talk @pedrommcmachado.bsky.social identifying predicted sig increase in RMDs in the coming years! #EULAR2025

And to finish, Professor Pedro Machado and Real world data vs Randomised trials... do we need both?

This afternoon, after extra-musculoskeletal manifestations (sorry, no photo) Rhys Hayward, from Northwick Park, covering non-pharmaxological management

... followed by Professor Karl Gaffney, discussing advanced therapeutics, to finish the morning session.

Professor Alex Bennett, on the contribution of MRI for #axSpA management.

Next up, a silhouette of Professor Raj Sengupta talking us through the diagnostic challenges in #Spondyloarthritis

Beautiful venue.

Helena Marzo-Ortega giving an overview of 50yrs of the concept of #spondyloarthritis.